Funding Opportunities

This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.

Standard submission dates apply for all listings, unless otherwise noted.

Guidance For Investigators Planning to Submit a Program Project Grant (P01)

NCI SBIR Contract Solicitation Digital Tools to Integrate Cancer Prevention Within Primary Care (https://sbir.cancer.gov/small-business-funding/contracts/current-solicitation/453) This solicitation will be open to applications through November 4th.

Notice: Internet links not permitted in NIH Grant Applications

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions PAR-20-266 (R61/R33 Clinical Trial Optional) R61, R33 Clinical Trial Optional 06/20/2023 Alexis Bakos, Ph.D., M.P.H., R.N.
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research NOT-CA-23-064 07/07/2023 Shizuko Sei, M.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-23-002 (R61 Clinical Trial Not Allowed) R61 Clinical Trial Not Allowed 09/02/2023 Guillermo Marquez, Ph.D.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-23-003 (R33 Clinical Trial Not Allowed) R33 Clinical Trial Not Allowed 09/02/2023 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-23-006 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/02/2023 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research RFA-CA-23-007 (U01 Clinical Trial Optional) U01 Clinical Trial Optional 09/02/2023 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-23-008 (U54 Clinical Trials Optional) U54 09/02/2023 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-23-009 (P01 Clinical Trial Optional) P01 Clinical Trial Optional 09/02/2023 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-23-010 (P50 Clinical Trial Optional) P50 Clinical Trial Optional 09/02/2023 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) RFA-CA-23-011 Clinical Trial Optional 09/02/2023 Guillermo Marquez, Ph.D.